deltatrials

Multiple myeloma Trials in Greenbrae, United States

Conditions / Multiple myeloma / Greenbrae, United States

Clinical trials for Multiple myeloma investigate a range of treatment strategies and patient populations.

17 total trials for this combination

Showing top 10 of 17 trials

Trials

NCT ID Title Status Phase
NCT02252172 Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Participants With Previously Untreated Multiple Myeloma COMPLETED PHASE3
NCT00761722 Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma COMPLETED PHASE1
NCT02465060 Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) ACTIVE_NOT_RECRUITING
NCT02477891 Early Access Treatment With Daratumumab for (Relapsed or Refractory) Multiple Myeloma APPROVED_FOR_MARKETING
NCT01734928 Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma COMPLETED PHASE3
NCT01335399 Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma COMPLETED PHASE3
NCT01239797 Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma COMPLETED PHASE3
NCT00507416 Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and Prednisone COMPLETED PHASE3
NCT01818752 Phase 3 Study of Carfilzomib, Melphalan, Prednisone vs Bortezomib, Melphalan, Prednisone in Newly Diagnosed Multiple Myeloma COMPLETED PHASE3
NCT02465060 Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) ACTIVE_NOT_RECRUITING

Related Pages